BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 20551826)

  • 1. HMGA2 is a sensitive but not specific immunohistochemical marker of vulvovaginal aggressive angiomyxoma.
    McCluggage WG; Connolly L; McBride HA
    Am J Surg Pathol; 2010 Jul; 34(7):1037-42. PubMed ID: 20551826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMGA2 Is a Useful Marker of Vulvovaginal Aggressive Angiomyxoma But May Be Positive in Other Mesenchymal Lesions at This Site.
    Harkness R; McCluggage WG
    Int J Gynecol Pathol; 2021 Mar; 40(2):185-189. PubMed ID: 32897956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMGA2 rearrangement in a case of vulvar aggressive angiomyxoma.
    Rabban JT; Dal Cin P; Oliva E
    Int J Gynecol Pathol; 2006 Oct; 25(4):403-7. PubMed ID: 16990720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggressive angiomyxoma [corrected] of the female genital tract and pelvis--clinicopathologic features with immunohistochemical analysis.
    Bigby SM; Symmans PJ; Miller MV; Dray MS; Jones RW
    Int J Gynecol Pathol; 2011 Sep; 30(5):505-13. PubMed ID: 21804399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review and update of morphologically bland vulvovaginal mesenchymal lesions.
    McCluggage WG
    Int J Gynecol Pathol; 2005 Jan; 24(1):26-38. PubMed ID: 15626915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent developments in vulvovaginal pathology.
    McCluggage WG
    Histopathology; 2009 Jan; 54(2):156-73. PubMed ID: 18637148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Aggressive angiomyxoma of the vulva. Case report and literature review].
    Nava Flores EL; Alvarez Blanco MA; Figueroa Vadillo J; Cruz Ortiz H
    Ginecol Obstet Mex; 2009 Oct; 77(10):487-90. PubMed ID: 19902678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selected case from the Arkadi M. Rywlin International Pathology Slide Club: aggressive angiomyxoma, left labial region in a postmenopausal woman.
    Gunawardane DN; Allen PW
    Adv Anat Pathol; 2013 Sep; 20(5):361-4. PubMed ID: 23939153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggressive angiomyxoma.
    Sutton BJ; Laudadio J
    Arch Pathol Lab Med; 2012 Feb; 136(2):217-21. PubMed ID: 22288973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggressive angiomyxoma of the vulva: Dramatic response to gonadotropin-releasing hormone agonist therapy.
    McCluggage WG; Jamieson T; Dobbs SP; Grey A
    Gynecol Oncol; 2006 Mar; 100(3):623-5. PubMed ID: 16246403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinicopathologic analysis of aggressive angiomyxoma in the pelvis and vulva of 8 cases].
    Liao Q; Liu Z; Zhang Y; He Q
    Zhonghua Fu Chan Ke Za Zhi; 2002 Jun; 37(6):359-62. PubMed ID: 12126573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of vulvar superficial angiomyxoma with necrotizing angiitis-like lesions and expression of granulocyte-colony stimulating factor.
    Okada Y; Mori H; Tsuji M; Yagi Y
    Pathol Res Pract; 2005; 201(2):145-52. PubMed ID: 15901137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular angiofibroma and related fibromatous lesions of the vulva: report of a series of cases with a morphological spectrum wider than previously described.
    McCluggage WG; Ganesan R; Hirschowitz L; Rollason TP
    Histopathology; 2004 Oct; 45(4):360-8. PubMed ID: 15469474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vulvar angiomyxoma, aggressive angiomyxoma, and angiomyofibroblastoma: an immunohistochemical and ultrastructural study.
    Alameda F; MunnĂ© A; BarĂ³ T; Iglesias M; Condom E; Lloreta-Trull J; Serrano S
    Ultrastruct Pathol; 2006; 30(3):193-205. PubMed ID: 16825121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggressive angiomyxoma of the pelvis. A case report.
    Melilli GA; Carriero C; Nappi L; Lapresa M; Caradonna F; Loizzi V; Selvaggi L
    Minerva Ginecol; 2000 Nov; 52(11):465-6. PubMed ID: 11256175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggressive angiomyxoma: a clinicopathologic study of 29 female patients.
    Fetsch JF; Laskin WB; Lefkowitz M; Kindblom LG; Meis-Kindblom JM
    Cancer; 1996 Jul; 78(1):79-90. PubMed ID: 8646730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and characterization of HMGA2 and HMGA1 rearrangements in mesenchymal tumors of the lower genital tract.
    Medeiros F; Erickson-Johnson MR; Keeney GL; Clayton AC; Nascimento AG; Wang X; Oliveira AM
    Genes Chromosomes Cancer; 2007 Nov; 46(11):981-90. PubMed ID: 17654722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aggressive angiomyxoma of the vulva and perineum].
    Habeck JO
    Zentralbl Pathol; 1992 Sep; 138(4):303-6. PubMed ID: 1420111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggressive angiomyxoma of pelvic parts exhibits oestrogen and progesterone receptor positivity.
    McCluggage WG; Patterson A; Maxwell P
    J Clin Pathol; 2000 Aug; 53(8):603-5. PubMed ID: 11002763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggressive angiomyxoma presenting as a vulval polyp.
    Srinivasan R; Mohapatra N; Malhotra S; Rao SK
    Indian J Cancer; 2007; 44(2):87-9. PubMed ID: 17938485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.